Enforcement and administrative action
注意喚起 disclosure naming 武田薬品工業株式会社
The published name has not been matched to a verified Corporate Number. Check the identity before attributing this record to a company.
- Action type
- 注意喚起
- Law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
- Authority
- Ministry of Health, Labour and Welfare
- Action date
- 4 February 2015
Published details
The manufacturer and marketer repeatedly distributed 'Requests for Proper Use' to healthcare professionals and others, providing warnings and cautions.
Machine-translated from the Japanese disclosure. The original Japanese text is available below.
Sources and saved materials
Review the source list, printable report and available saved files.
Evidence pack ¥4,980tax included · one-time purchase
Available PDFs, images and other files vary by record. Check the included materials before purchasing; a source URL does not guarantee an original file is included.
Purchase and download pages are currently in Japanese. Materials retain the original source language.
Official source URL recorded · Queued for preservation
Source links and saved files require purchase. Already purchased?
Action details
- Industry (as published)
- 医薬品
Additional published details
The Ministry of Health, Labour and Welfare has revised the 'Precautions for Use' section of the package insert for the antiepileptic and bipolar disorder medication 'Lamictal Tablets' (attached document 1), based on reports of severe skin disorders leading to death. Additionally, it instructed manufacturers and marketers to promptly alert healthcare professionals through a 'Safety Information (Blue Letter)' (attached document 2).
Show original Japanese text
製造販売業者が、複数回にわたり「適正使用のお願い」を医療関係者等に配布し、注意喚起してきた。
Sources, saved materials and verification
Source verification
Public-source and preservation status
- Publishing authority
- Ministry of Health, Labour and Welfare
- Official source URL
- Recorded by RegBase
- Entity match
- Not confirmed; shown under the published name
- Kiroku preservation
- Queued for preservation
“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.
Open Sources and saved materials on this page to review the available pack contents.
About this action and law
This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
English translations are for reference. Verify important decisions against the original Japanese disclosure. View the Japanese page.